Lucence

Earlier Detection. Better Health.

Singapore, Singapore · Founded 2016 · $45.0M raised

Headquarters
Singapore
Founded
2016
Business Model
B2B
Total Funding
$45.0M
Last Round
$25.0M Series BJan 2022
Rounds
2

About

At Lucence, earlier detection is the key to longevity — the company advances detection of health conditions before symptoms even appear so doctors can guide patients with a personalized health action plan. Founded in 2016 as a spin-off from Singapore's A*STAR, Lucence offers a range of ultrasensitive liquid biopsy tests, including LiquidHALLMARK for therapy selection and LucenceINSIGHT for multi-cancer early detection.

Summary

Lucence is a Diagnostics company based in Singapore, Singapore, founded in 2016. It has raised $45.0M in total across 2 rounds, most recently a $25.0M Series B round in Jan 2022. Investors include IHH Healthcare, SGInnovate and Heliconia Capital Management.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJan 2022
$25.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lucence on Indexed.vc
<a href="https://indexed.vc/companies/lucence"><img src="https://indexed.vc/api/badge/company/lucence" alt="Lucence on Indexed.vc" width="260" height="76" /></a>